https://www.selleckchem.com/pr....oducts/Sunitinib-Mal
The hazard for technical complications and implant loss peaked at 0.7years and 0.2years, respectively, while the hazard for peri-implantitis was consistent throughout the observation period. The overall proportion of satisfied patients at 9years was high (95%), and only minor differences between individuals with and without complications were noted. Complications following implant-supported restorative therapy were common findings. Extent of therapy and periodontitis were identified as risk factors. While technical com
Like
Comment
Share
